19 research outputs found
HEMATOLOGIC AND CLINICAL INDICES OF MALARIA IN A SEMI-IMMUNE POPULATION OF WESTERN THAILAND
This study examines hematologic profiles of persons with acute Plasmodium falciparum or P. vivax
infection in Maesod on Thailand’s western border with Myanmar compared with febrile, non-parasitemic persons also
reporting to malaria clinics. Nine hundred seventy-nine subjects were malaria-negative, 414 were infected with P.
falciparum, and 646 were infected with P. vivax. Persons with patent parasitemia tended to have significantly lower white
blood cell, red blood cell, platelet, and hemoglobin levels than those who were malaria-negative. For the first time, a
parallel trend in thrombocytopenia with parasitemia was found to be associated with both P. falciparum, and P. vivax
infection. Using logistic regression, persons with platelet counts < 150,000/µL were 12−15 times more likely to have
malaria than persons with platelet counts ≥ 150,000/µL. This study supplements previous literature on the hematologic
effects of malaria and helps define those alterations for a semi-immune population. Thrombocytopenia is identified as
a key indicator of malaria in these febrile patients
Testing for Coccidioidomycosis among Patients with Community-Acquired Pneumonia
Lack of testing may lead to underdiagnosis and underestimates of disease prevalence
Testing for Coccidioidomycosis among Patients with Community-Acquired Pneumonia
Lack of testing may lead to underdiagnosis and underestimates of disease prevalence
The Public Health Impact of Coccidioidomycosis in Arizona and California
The numbers of reported cases of coccidioidomycosis in Arizona and California have risen dramatically over the past decade, with a 97.8% and 91.1% increase in incidence rates from 2001 to 2006 in the two states, respectively. Of those cases with reported race/ethnicity information, Black/African Americans in Arizona and Hispanics and African/Americans in California experienced a disproportionately higher frequency of disease compared to other racial/ethnic groups. Lack of early diagnosis continues to be a problem, particularly in suspect community-acquired pneumonia, underscoring the need for more rapid and sensitive tests. Similarly, the inability of currently available therapeutics to reduce the duration and morbidity of this disease underscores the need for improved therapeutics and a preventive vaccine
Boost Camp’, a universal school-based transdiagnostic prevention program targeting adolescent emotion regulation; evaluating the effectiveness by a clustered RCT : a protocol paper
Abstract Background The transition from childhood into adolescence can be considered as a critical developmental period. Moreover, adolescence is associated with a decreased use of adaptive emotion regulation strategies and an increased use of maladaptive emotion regulation strategies increasing the risk of emotional problems. Targeting emotion regulation is therefore seen as an innovative prevention approach. The present study aims to evaluate the effectiveness of Boost camp, an innovative school-based prevention program targeting ER, on adolescents’ emotion regulation skills and emotional wellbeing. Also secondary outcomes and possible moderators will be included. Methods The aim is to reach 300 adolescents (16 class groups, 6 schools) in their first year of high school. A clustered Randomized Controlled Trial (RCT) with two conditions, intervention (n = 150) and control (n = 150), will be set up. Adolescents in the intervention condition will receive 14 lessons over the course of 2 days, followed by Booster sessions, and will be compared with adolescents in a non-intervention control group. The outcomes will be measured by self-report questionnaires at baseline, immediately after Boost camp, and at three and 6 months follow-up. Discussion Data-collection is planned to be completed in May 2018. Data-analyses will be finished the end of 2018. The presented paper describes the Boost camp program and the clustered RCT design to evaluate its effectiveness. It is expected that Boost camp will have beneficial effects. If found effective, Boost camp will have the potential to increase adolescent’s ER and well-being, and reduce the risk to become adults in need. The trials is registered on the 13th of June 2017 in ISRCTN registry [ISRCTN68235634]
Enhanced Surveillance of Coccidioidomycosis, Arizona, USA, 2007–2008
Additional public and provider education are needed to reduce delays in diagnosis